IFNA1 and systemic lupus erythematosus: The rare variants identified in SLE patients, as opposed to those exclusively found in the control group, hinder the suppression of IRF5 and IFN in human B-cell lines and augment the presence of pathogenic lymphocytes in mice prone to lupus [22].